A case report of rheumatoid arthritis complicated with rapidly progressive interstitial pneumonia, multiple bullae and pneumomediastinum, which was successfully treated with tacrolimus

Japanese Journal of Clinical Immunology

Volumn 31, Issue 1, 2008, Pages 62-67

  Ochi, Sae ^a   Kubota, Tetsuo ^a   Sugihara, Takahiko ^a   Ogawa, Jun ^a   Komano, Yukiko ^a   Nonomura, Yoshinori ^a   Miyasaka, Nobuyuki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

interstitial pneumonia; multiple bullae; pneumomediastinum; rheumatoid arthritis; tacrolimus

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ARTICLE; BLISTER; CASE REPORT; FEMALE; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG DISEASE; MIDDLE AGED; PNEUMOMEDIASTINUM; RHEUMATOID ARTHRITIS;

ARTHRITIS, RHEUMATOID; BLISTER; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG DISEASES; LUNG DISEASES, INTERSTITIAL; MEDIASTINAL EMPHYSEMA; MIDDLE AGED; TACROLIMUS;

EID: 42449124223     PISSN: 09114300     EISSN: 13497413     Source Type: Journal    
DOI: 10.2177/jsci.31.62     Document Type: Article

References (17)

1. Hakala, M.: Poor prognosis in patients with rheumatoid arthritis hospitalized for interstitial lung fibrosis. Chest 93: 114–118, 1988.
2. McCarey, D. W., et al.: Tacrolimus therapy in rheumatoid arthritis. Rheumatol (Oxford). 43: 946–94, 2004.
3. Takada, K., et al.: Polymyositis/dermatomyositis and interstitial lung disease: A new therapeutic approach with T-cell-specific immunosuppressants. Autoimmunity 38: 383–392, 2005.
4. Margaret, R., et al.: Treatment of antisyn-thetase-associated interstitial lung disease with tacrolimus. Arthritis Rheum. 52: 2439–2446, 2005.
5. Ochi, S., et al.: Favorable outcomes with tacrolimus in two patients with refractory interstitial lung disease associated with polymyositis /dermatomyositis. Clin. Exp. Rheumatol. 23: 707–710, 2005.
6. Shimojima, Y., et al.: Efficacy of tacrolimus in treatment of polymyositis associated with myasthenia gravis. Clin. Rheumatol. 34: 262–265, 2004.
7. Mok, C. C., et al.: Tacrolimus for induction therapy of diffuse proliferative lupus nephritis: an open-labeled pilot study. Kidney Int. 68: 813–817, 2005.
8. Morton, S. J., et al.: Cyclosporin and tacrolimus: their use in a routine clinical setting for scleroderma. Rheumatology 39: 865–869, 2000.
9. Suzuki, T., et al.: Bilateral pneumothoraces with multiple bullae in a patient with asymptomatic bronchiolitis obliterans 10 years after bone marrow transplantation. Bone Marrow Transplant. 23: 829–831, 1999.
10. Taruya, K., et al.: Multiple rheumatoid nodules with rapid thin-walled cavity formation producing pneumothorax. J. Thorac. Imaging 20: 47–49, 2005.
11. Ansul, P., et al.: Persistent pneumomediastinum in interstitial fibrosis associated with rheumatoid arthritis. Chest 117: 1809–1813, 2000.
12. Liu, J.: FK506 and cyclosporine, molecular probes for studying intracellular signal transduction. Immnol. Today 14: 290–295, 1993.
13. Dumont, F. J.: FK506, an immunosuppressant targeting calcineurin function. Curr. Med. Chem. 7: 731–74, 2000.
14. Cairn, J., et al.: Time-related changes in pulmonary function after conversion to tacrolimus in bronchiolitis obliterans syndrome. J. Heart Lung Transplant. 22: 50–57, 2003.
15. Mitsuki, T., et al.: Successful treatment with tacrolimus in a case of refractory dermatomyositis. Intern. Med. 44: 1197–1199, 2005.
16. Sloper, C. M., et al.: Tacrolimus (FK506) in their treatment of posterior uveitis refractory to cyclosporine. Ophthalmology 106: 723–72, 1999.
17. Koga, T., et al.: Pulmonary infiltrates recovered by FK506 in a patient with Behçet's disease. Chest 104: 309–311, 1993.